期刊文献+

永生化人胎肝细胞系LC-1的建立

Establishment of immortalized human fetal hepatocyte line LC-1
下载PDF
导出
摘要 目的建立人源性永生化肝细胞。方法利用含有SV40T和EGFP基因的双顺反子逆转录病毒表达载体pLNC-TIGlox,转染包装细胞PT67;取病毒上清液感染原代培养的人胎肝细胞,用G418筛选成功转导的永生化细胞系;用细胞计数法测定永生化细胞增殖特性,免疫细胞化学染色检测肝细胞特征蛋白表达,放免法和自动生化仪检测清蛋白和尿素氮合成功能。结果获得的一个细胞系命名为LC-1,其细胞群体倍增时间约为17h,可表达清蛋白、CK18肝细胞特征和CK19等胆管特征蛋白,具有清蛋白与尿素氮合成功能。结论成功建立了具有良好的增殖能力、分化状态、肝细胞生物学特征的永生化肝细胞系。 Objective To establish immortalized human hepatocyte lines. Methods PT67 cells were transfected with pLNCTI- Glox,an ambicistron retroviral expression vector previously constructed by our study group and containing ST40 and EGFP. Primary human fetal hepatocytes were infected with virus-contained supertanants and the successfully transducted cell lines were screened with G418. The proliferation characteristics of the cells were evaluated with cytometry. Hepatocyte-specific protein expression was detected with immunocytochemical staining. Synthesis of albumin and urea nitrogen was evaluated with radioimmunoassay and auto- biocheinical assay. Oncogenicity of the cell line was assessed with tumor-forming test. Results A cell line was obtained and named LC-1. The population doubling time of LC-1 ceils was 17h approximately. LC-1 cells could express hepatocyte-specific proteins such as albumin,cytokeratin (CK) 18 and CK19. LC-1 cells could synthesize albumin and urea. Conelosion We successfully established immortalized human bepatocytes retaining the characteristics of differentiated hepatocytes.
出处 《重庆医学》 CAS CSCD 北大核心 2009年第21期2672-2673,2676,共3页 Chongqing medicine
基金 国家自然科学基金资助项目(30100080)
关键词 肝细胞 胚胎 永生化 hepatocytes fetus immortalization
  • 相关文献

参考文献1

二级参考文献9

  • 1Watanabe N, Odagiri H, Totsuka E, Sasaki M. A new method to immortalize primary cultured rat hepatocytes. Transplant Proc 2004,36:2457-2461.
  • 2Wege H, Le HT, Chui MS, Liu L, Wu J, Giri R, Malhi H, Sappal BS, Kumaran V, Gupta S, Zern MA. Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential. Gastroenterology 2003,124:432-444.
  • 3Kobayashi N,Noguchi H, Westerman KA, Watanabe T,Matsumura T, Totsugawa T, Fujiwara T, Leboulch P, Tanaka N. Cre/loxP-based reversible immortalization of human hepatocytes. Cell Transplant 2001,10:383-386.
  • 4Noguchi H, Kobayashi N, Westerman KA, Sakaguchi M, Okitsu T, Totsugawa T, Watanabe T, Matsumura T, Fujiwara T, Ueda T, Miyazaki M, Tanaka N, Leboulch P. Controlled expansion of human endothelial cell populations by Cre-loxP-based reversible immortalization Hum Gene Ther 2002:13:321-334.
  • 5Min KJ, Young CJ, Sun KM, Chang KS. In vivo excision and amplification of large human genomic segments using the Cre/loxP-and large T antigen/SV40 ori-mediated machinery.J Biotechnol 2004,110:227-233.
  • 6Kobayashi N, Okitsu T, Nakaji S, Tanaka N. Hybrid bioartificial liver:establishing a reversibly immortalized human hepatocyte line and developing a bioartificial liver for practical use. J Artif Organs 2003,6:236-244.
  • 7Kobayashit N, Tanaka N. Engineering of human hepatocyte lines for cell therapies in humans:prospects and remaining hurdles. Cell Transplant 2002,11:417-420.
  • 8Sato Y, Endo H, Ajiki T, Hakamata Y, Okada T, Murakami T,Kobayashi E. Establishment of Cre/LoxP recombination system in transgenic rats. Biochem Biophys Res Commun 2004,319:1197-1202.
  • 9李俊刚,陈耀凯,王宇明.SV40T外显子的拼接及逆转录病毒载体pLLTSN的构建[J].世界华人消化杂志,2004,12(5):1104-1107. 被引量:3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部